Transforming the management
of Mycobacterial diseases

Twitter Youtube Linkedin Envelope
Actiphage TB awarded US Patent grant for diagnostic kit
Read more
Actiphage TB awarded US Patent grant for diagnostic kit
“Significant association between positive Actiphage test and features of progressive TB infection.”
Read more
Lancet article - PET-CT features observed following M tuberculosis exposure. biomarkers show those at high risk of TB

Actiphage – Confidence
to test for active TB

Loading...

 

PBD Biotech – developers of Actiphage®, a novel bacteriophage-based diagnostic.

Actiphage rapidly and accurately detects and identifies live mycobacteria – the pathogen that causes human tuberculosis, bovine tuberculosis and Johne’s Disease – from a sample of blood or milk.

Actiphage offers the potential for effective detection, management, and eradication of these diseases.

Please contact us if you would like to discuss this further or to use the testing service.

PBD Biotech developers of Actiphage TB

Rapid blood test for Johne’s now available – enquire here 

Latest

Loading...
No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals
March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet are still infective, according to a study led by Amsterdam UMC, published in the Lancet. 
No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals

No persistent cough in 4 out of 5 with Tuberculosis Lancet paper reveals
March 21, 2024
80 percent of people with tuberculosis (TB), the world’s most deadly infection, do not have a persistent cough and yet...
Certificate of Grant (web)

Actiphage TB patent granted in South Africa
November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements the regional West Africa patent gained earlier this year.
Certificate of Grant (web)

Actiphage TB patent granted in South Africa
November 14, 2023
Grant of a patent has been awarded to PBD Biotech for its Actiphage diagnostic for incipient tuberculosis in South Africa, this complements...
1 2